<DOC>
	<DOCNO>NCT00005106</DOCNO>
	<brief_summary>The purpose study look effect different anti-HIV drug combination body fat change HIV-positive patient never receive anti-HIV therapy .</brief_summary>
	<brief_title>A Comparison Three Anti-HIV Drug Combinations HIV-Infected Patients</brief_title>
	<detailed_description>Patients randomize receive stavudine plus lamivudine plus nelfinavir , Combivir ( zidovudine plus lamivudine ) plus nelfinavir , Combivir plus abacavir . Patients stratify 2 group base screen plasma HIV-1 RNA : ( 1 ) great 1,000 100,000 copies/ml ( 2 ) great 100,000 200,000 copies/ml . Measurements evaluation assessment body fat composition , virologic immunologic outcome , marker alteration carbohydrate lipid metabolism , safety perform Baseline , Weeks 4 , 8 , 16 , 24 , every 12 week thereafter Week 96 withdrawal . In addition , health-related quality life health care resource utilization data collect specified treatment visit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Lamivudine , zidovudine drug combination</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are least 18 year old . Are HIVpositive . Have CD4 count great 50 cells/mm3 . Have viral load great 1,000 copies/ml less 200,000 copies/ml . Have never receive antiHIV medication . ( However , less 1 week therapy lamivudine protease inhibitor le 4 week therapy nucleoside reverse transcriptase inhibitor [ NRTIs ] allow . No therapy nonnucleoside reverse transcriptase inhibitor [ NNRTIs ] allow . ) Can bear child agree use effective method birth control study . Hormonal method birth control ( birth control pill ) consider effective study . Exclusion Criteria Patients eligible study : Have active AIDSdefining opportunistic infection disease , doctor 's opinion , would make unable participate . Are unable , opinion doctor , follow dose schedule followup visit schedule . Have substance abuse problem would interfere take medication correctly attend clinic visit . Are enrol another study . Can take medication mouth absorb drug . Have hepatitis . Have serious medical condition diabetes , congestive heart failure , heart disease . Need chemotherapy radiation therapy ( except local treatment Kaposi 's sarcoma ) . Are take certain medication . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2000</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Stavudine</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Adipose Tissue</keyword>
	<keyword>Lipodystrophy</keyword>
	<keyword>abacavir</keyword>
</DOC>